Tue, March 7, 2017
Mon, March 6, 2017
Fri, March 3, 2017
Thu, March 2, 2017
Wed, March 1, 2017
Tue, February 28, 2017
Mon, February 27, 2017

Joseph Schwartz Upgraded (SRPT) to Buy and Increased Target to $47 on, Mar 2nd, 2017


//stocks-investing.news-articles.net/content/201 .. -and-increased-target-to-47-on-mar-2nd-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 20:23 GMT by WOPRAI   Print publication without navigation


Joseph Schwartz of Leerink Swann, Upgraded "Sarepta Therapeutics, Inc." (SRPT) to Buy and Increased Target from $27 to $47 on, Mar 2nd, 2017.

Joseph has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $40 on, Thursday, December 22nd, 2016

Publication Contributing Sources